Literature DB >> 16524997

Effects of attributing serious mental illnesses to genetic causes on orientations to treatment.

Jo C Phelan1, Lawrence H Yang, Rosangely Cruz-Rojas.   

Abstract

OBJECTIVE: Professional services for persons with serious mental illnesses are underutilized. The genetics revolution has the potential to increase professional help seeking by increasing biomedical interpretations of mental illness among the public. The objective of this study was to assess whether genetic attributions for serious mental illnesses are associated with more positive orientations to professional treatment among members of the general public.
METHODS: Data from two nationally representative surveys were analyzed. First, associations between perceptions of genetic causes of both schizophrenia and depression and treatment recommendations and perceived treatment effectiveness were assessed in a vignette study that was part of the 1996 General Social Survey (GSS). Second, the effect of various descriptions of the role of genetic factors in schizophrenia and depression on perceived treatment effectiveness was assessed in a vignette experiment conducted in 2002-2003.
RESULTS: Perception of genetic causes was associated with more recommendations for mental hospitalization and prescription medication but not with more recommendations to see a psychiatrist, a therapist, or a general medical practitioner. Perception of genetic causes was not related to perceived treatment effectiveness in the GSS, and genetic causes as described in the vignette were associated with lower perceived effectiveness of treatment.
CONCLUSIONS: Increasing emphasis on genetic causes of mental illnesses may have multifaceted effects on orientations to professional treatment. Genetic attributions appear to direct people's help seeking toward the most extreme or biological forms of intervention, possibly because people view genetically influenced disorders as more serious and chronic. At the same time, such attributions lead to pessimism that intervention will be effective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524997     DOI: 10.1176/appi.ps.57.3.382

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  56 in total

1.  WPA guidance on steps, obstacles and mistakes to avoid in the implementation of community mental health care.

Authors:  Graham Thornicroft; Atalay Alem; Renato Antunes Dos Santos; Elizabeth Barley; Robert E Drake; Guilherme Gregorio; Charlotte Hanlon; Hiroto Ito; Eric Latimer; Ann Law; Jair Mari; Peter McGeorge; Ramachandran Padmavati; Denise Razzouk; Maya Semrau; Yutaro Setoya; Rangaswamy Thara; Dawit Wondimagegn
Journal:  World Psychiatry       Date:  2010-06       Impact factor: 49.548

2.  Can antistigma campaigns be improved? A test of the impact of biogenetic vs psychosocial causal explanations on implicit and explicit attitudes to schizophrenia.

Authors:  Tania M Lincoln; Elisabeth Arens; Cornelia Berger; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-12-01       Impact factor: 9.306

Review 3.  Measuring the impact of programs that challenge the public stigma of mental illness.

Authors:  Patrick W Corrigan; Jenessa R Shapiro
Journal:  Clin Psychol Rev       Date:  2010-06-30

4.  Negotiating the Relationship Between Addiction, Ethics, and Brain Science.

Authors:  Daniel Z Buchman; Wayne Skinner; Judy Illes
Journal:  AJOB Neurosci       Date:  2010-01

5.  "Not all my fault": genetics, stigma, and personal responsibility for women with eating disorders.

Authors:  Michele M Easter
Journal:  Soc Sci Med       Date:  2012-07-04       Impact factor: 4.634

Review 6.  The public stigma of mental illness: what do we think; what do we know; what can we prove?

Authors:  Bernice A Pescosolido
Journal:  J Health Soc Behav       Date:  2013-01-16

7.  Psychiatric Genetics in Child Custody Proceedings: Ethical, Legal, and Social Issues.

Authors:  Maya Sabatello; S Appelbaum
Journal:  Curr Genet Med Rep       Date:  2016-06-30

Review 8.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

9.  Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Authors:  Theresa M Marteau; Marcus R Munafò; Paul Aveyard; Chloe Hill; Sophia Whitwell; Thomas A Willis; Rachel A Crockett; Gareth J Hollands; Elaine C Johnstone; Alison J Wright; A Toby Prevost; David Armstrong; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMC Public Health       Date:  2010-11-09       Impact factor: 3.295

Review 10.  Behavioral Genetics in Criminal and Civil Courts.

Authors:  Maya Sabatello; Paul S Appelbaum
Journal:  Harv Rev Psychiatry       Date:  2017 Nov/Dec       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.